Cyril Quessada

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis

M. Spedding, J. Loeffler, Alexandra Bouscary, 2019, Front. Pharmacol..

Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?

J. Loeffler, Alexandra Bouscary, Cyril Quessada, 2021, Cells.

Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases.

M. Spedding, J. Loeffler, Alexandra Bouscary, 2020, European journal of pharmacology.

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target

S. Rossi, R. Coccurello, J. Loeffler, 2020, iScience.

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1G93A mice

A. Musarò, L. Pieroni, A. Urbani, 2021, British journal of pharmacology.

LSP2-9166, an orthosteric mGlu4 and mGlu7 receptor agonist, reduces cocaine self-administration under a progressive ratio schedule in rats

Romain Bourdy, J. Zwiller, F. Acher, 2020, Neuroscience Letters.

Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

M. Spedding, J. Loeffler, Alexandra Bouscary, 2020, Seminars in cell & developmental biology.

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1 G93G Mice Predates Disease Onset and is a Promising Therapeutic Target

R. Coccurello, J. Loeffler, F. Giannini, 2019, SSRN Electronic Journal.